Release Date: 2023-09-14

Management of Hyperglycemia in the Emergency Department

Release Date: 2023-09-14

Management of hyperglycemia in the emergency department (ED) requires a systematic approach to stabilize patients and address the underlying causes. Initial assessment includes evaluating vital signs, mental status, and symptoms that may indicate complications such as diabetic ketoacidosis (DKA) or hyperosmolar hyperglycemic state (HHS). Laboratory tests, including blood glucose levels, electrolytes, renal function, and arterial [...]

Media Type
  • PDF

Buy from

Price may vary by retailers

Work TypeBook Chapter
Published inCurrent Perspective on Diabetes Mellitus in Clinical Sciences
First Page201
Last Page210
DOIhttps://doi.org/10.69860/nobel.9786053359111.18
ISBN978-605-335-911-1 (PDF)
LanguageENG
Page Count10
Copyright HolderNobel Tıp Kitabevleri
Licensehttps://nobelpub.com/publish-with-us/copyright-and-licensing
Management of hyperglycemia in the emergency department (ED) requires a systematic approach to stabilize patients and address the underlying causes. Initial assessment includes evaluating vital signs, mental status, and symptoms that may indicate complications such as diabetic ketoacidosis (DKA) or hyperosmolar hyperglycemic state (HHS). Laboratory tests, including blood glucose levels, electrolytes, renal function, and arterial blood gases, are crucial to determine severity and guide treatment. Prompt initiation of intravenous fluids, typically isotonic saline, corrects dehydration and improves tissue perfusion. Insulin therapy is essential and administered intravenously as a continuous infusion or subcutaneously based on the severity of hyperglycemia. Regular monitoring of blood glucose levels ensures effective insulin dosing and prevents hypoglycemia. Addressing underlying triggers like infections or medication-related causes complements pharmacological treatment. Collaborative care involving specialists and diabetes educators optimizes management and facilitates patient transition to ongoing care after ED discharge, emphasizing education on medication adherence and lifestyle modifications to prevent the recurrence of hyperglycemic crises.
  • National Hospital Ambulatory Medical Care Survey: 2010 Emergency Department Summary Tables. The Ambulatory and Hospital Care Statistics Branch, U.S. Bureau of the Census

  • Yan J.W., Gushulak K.M., Columbus M.P., Aarsen K.V., Hamelin A.L., Wells G.A. and Stiell I.G. Risk factors for recurrent emergency department visits for hyperglycemia in patients with diabetes mellitus. International Journal of Emergency Medicine. 2017; 10:23

  • Alourfi Z and Homsi H. Precipitating factors, outcomes, and recurrence of diabetic ketoacidosis at a university hospital in Damascus. Avicenna J Med. 2015; 5(1):11–5

  • Kitabchi A.E., Umpierrez G.E., Miles J.M. and Fisher J.N. Hyperglycemic crises in adult patients with diabetes. Diabetes care. 2009; 32:1335–43.

  • Larsen, C.M., Faulenbach, M., Vaag, A., Vølund, A., Ehses, J.A., Seifert, B.,... Donath MY. Interleukin- 1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med. 2007; 356:1517.

  • Lawrence, J.M., Divers, J., Isom, S., Saydah, S., Imperatore, G., Pihoker, C.,...Liese AD. Trends in Prevalence of Type 1 and Type 2 Diabetes in Children and Adolescents in the US, 2001-2017. JAMA. 2021; 326:717.

  • Harris M.I. Impaired glucose tolerance in the U.S. population. Diabetes Care. 1989; 12:464

  • Lee, P.G. and Halter, J.B. The Pathophysiology of Hyperglycemia in Older Adults: Clinical Considerations. Diabetes Care. 2017;40:444–452

  • Li, Y., Xu, W., Liao, Z., Yao, B., Chen, X., Huang, Z.,...Weng, J. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of beta-cell function. Diabetes Care. 2014; 27:2597.

  • Kitabchi, A.E., Umpierrez, G.E., Fisher, J.N., Murphy, M.B. and Stentz, F.B. Thirty years of personal experience in hyperglycemic crises: diabetic ketoacidosis and hyperglycemic hyperosmolar state. J Clin Endocrinol Metab. 2008; 93:1541.

  • Türkiye Endokrinoloji ve Metabolizma Derneği Diabetes Mellitus ve Komplikasyonlarının Tanı, Tedavi ve İzlem Kılavuzu. 2022; ISBN: 978-605-66410-5-3

  • Martin, W.G., Galligan, J., Simpson, S., Greenaway, T. and Burgess, J. Admission blood glucose predicts mortality and length of stay in patients admitted through the emergency department. Intern Med J. 2015; 45:916–24.

  • Echouffo-Tcheugui, J.B. and Garg, R. Management of Hyperglycemia and Diabetes in the Emergency Department. Curr Diab Rep. 2017; 17: 56

  • Morris, L.R. and Kitabchi, A.E. Effi cacy of low-dose insulin therapy for severely obtunded patients in diabetic ketoacidosis. Diabetes Care. 1980; 3:53

  • Popli, S., Sun, Y., Tang, H., Kjellstrand, C.M., Tzamaloukas, A.H. and Ing, T.S. Acidosis and coma in adult diabetic maintenance dialysis patients with extreme hyperglycemia. International Urology and Nephrology. 2013; volume 45, pages 1687–1692.

  • Pasquel, F.J. and Umpierrez, G.E. Hyperosmolar Hyperglycemic State: A Historic Review of the Clinical Presentation, Diagnosis, and Treatment. Diabetes Care. 2014; 37:3124–3131

  • Nardonea, R.,Brigoc, F. and Trinkaa, E. Acute Symptomatic Seizures Caused by Electrolyte Disturbances. J Clin Neurol. 2016; 12(1):21-33.

  • Bratusch-Marrain, P.R, Komajati, M. and Waldhausal, W. The effect of hyperosmolarity on glucose metabolism. Pract Cardiol. 1985; 11:153.

  • Nyenwe, E.A. and Kitabchi, A.E. Evidence-based management of hyperglycemic emergencies in diabetes mellitus. Diabetes Res Clin Pract. 2011; 94:340.

  • Savage, M.W., Dhatariya, K.K., Kilvert A., Rayman G., Rees J.A., Courtney C.H.,...Hamersley M.S. Joint British Diabetes Societies guideline for the management of diabetic ketoacidosis. Diabet Med. 2011; 28:508

  • Ennis, E.D., Stahl, E.J. and Kreisberg, R.A. The hyperosmolar hyperglycemic syndrome. Diabetes Rev. 1994; 2:115

  • Dhatariya, K.K. and Vellanki, P. Treatment of Diabetic Ketoacidosis (DKA)/Hyperglycemic Hyperosmolar State (HHS): Novel Advances in the Management of Hyperglycemic Crises (UK Versus USA). Curr Diab Rep. 2017; 17: 33.

  • Wachtel, T.J. The diabetic hyperosmolar state. Clin Geriatr Med. 1990; 6:797.

  • Hirsch, I.B. and Draznin, B. Transition of Patients to and from Insulin Degludec: A Clinical Challenge. J Clin Endocrinol Metab. 2020; 105.

  • Umpierrez, G., and Korytkowski, M. Diabetic emergencies — ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia. Nature Reviews Endocrinology. 2016; 12(4), 222–232.

  • Nyenwe, E. A. and Kitabchi, A. E. The evolution of diabetic ketoacidosis: An update of its etiology, pathogenesis and management. Metabolism. 2016; 65(4), 507–521.

  • Bedinger, D. H. and Adams, S. H. Metabolic, anabolic, and mitogenic insulin responses: A tissue-specifi c perspective for insulin receptor activators. Molecular and Cellular Endocrinology. 2015; 415, 143–156.

  • Gosmanov, A. R., Gosmanova, E. and Dillard-Cannon, E. Management of adult diabetic ketoacidosis. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2014; 255.

  • Padilla, A.J. and Loeb, J.N. “Low-dose” versus “high-dose” insulin regimens in the management of uncontrolled diabetes. A survey. Am J Med. 1977; 63:843.

  • Umpierrez, G.E., Latif, K., Stoever, J., Cuervo, R., Park, L.,... Kitabchi, A.E. Effi cacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. Am J Med. 2004; 117:291.

  • Umpierrez, G.E., Cuervo, R., Karabell A., Latif, K., Freire, A.X. and Kitabchi, A.E. Treatment of diabetic ketoacidosis with subcutaneous insulin aspart. Diabetes Care. 2004; 27:1873.

  • Andrade-Castellanos, C. A., Colunga-Lozano, L. E., Delgado-Figueroa, N. and Gonzalez-Padilla, D. A. Subcutaneous rapid-acting insulin analogues for diabetic ketoacidosis. 2014; Cochrane Database of Systematic Reviews.

  • Moraes, A. G. de and Surani, S. Effects of diabetic ketoacidosis in the respiratory system. World Journal of Diabetes. 2019; 10(1), 16–22.

  • Brochard, L., Slutsky, A. and Pesenti, A. Mechanical Ventilation to Minimize Progression of Lung Injury in Acute Respiratory Failure. American Journal of Respiratory and Critical Care Medicine. 2017; 195(4), 438–442.

Share This Chapter!